SANGAMO THERAPEUTICS, INC of RICHMOND, CA filed a DEF 14A with the SEC on 2021-04-02. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | GRAPHIC | board_representationximage.jpg |
| 3 | GRAPHIC | macraesignaturea021.jpg |
| 4 | GRAPHIC | sangamo-2021cdagraphiccash.jpg |
| 5 | GRAPHIC | sangamo-2021cdagraphicceo2.jpg |
| 6 | GRAPHIC | sangamo-2021cdagraphicfact.jpg |
| 7 | GRAPHIC | sangamo-2021cdagraphicprim.jpg |
| 8 | GRAPHIC | sgmoproxycardp11.jpg |
| 9 | GRAPHIC | sgmoproxycardp21.jpg |
Showing 12 of 45 filings.
| Filed | Form |
|---|---|
| 2025-04-30 | DEF 14A |
| 2024-04-19 | DEF 14A |
| 2024-04-03 | PRE 14A |
| 2023-04-17 | DEF 14A |
| 2023-04-05 | PRE 14A |
| 2022-04-29 | DEFA14A |
| 2022-04-01 | DEF 14A |
| 2021-04-02 | DEF 14A |
| 2020-05-08 | DEFA14A |
| 2020-04-02 | DEF 14A |
| 2020-03-23 | PRE 14A |
| 2019-04-25 | DEFA14A |